Skip to main content
Top
Published in: Pediatric Nephrology 9/2014

01-09-2014 | Original Article

Regional citrate anticoagulation for pediatric CRRT using integrated citrate software and physiological sodium concentration solutions

Authors: Jean-Michel Liet, Emma Allain-Launay, Bénédicte Gaillard-LeRoux, François Barrière, Alexis Chenouard, Jean-Marc Dejode, Nicolas Joram

Published in: Pediatric Nephrology | Issue 9/2014

Login to get access

Abstract

Background

In continuous renal replacement therapy (CRRT), regional citrate anticoagulation offers an attractive alternative to heparinization, especially for children with a high bleeding risk.

Methods

We report on a new management approach to CRRT using integrated citrate software and physiological sodium concentration solutions. Convective filtration was performed with pre-filter citrate anticoagulation using an 18 mmol/L citrate solution and a post-filter replacement fluid. The citrate flow rate was automatically adjusted to the blood flow rate by means of integrated citrate software. Similarly, calcium was automatically infused into children to maintain their blood calcium levels within normal range.

Results

Eleven CRRT sessions were performed (330 h) in seven critically ill children aged 3–15 years (extreme values 15–66 kg). Disease categories included sepsis with multiorgan dysfunction (n = 2) and hemolytic uremic syndrome (n = 5). Median effluent dose was 2.1  (extreme values 1.7–3.3) L/h/1.73 m2. No session had to be stopped because of metabolic complications. Calcium levels, both in the circuits and in the circulating blood of the children, remained stable and secure.

Conclusions

Regional citrate anticoagulation can be used in children with a body weight of >15 kg using integrated citrate software and commercially available solutions with physiological sodium concentrations in a safe, effective and convenient procedure.
Literature
1.
go back to reference Wu MY, Hsu YH, Bai CH, Lin YF, Wu CH, Tam KW (2012) Regional citrate versus heparin anticoagulation for continuous renal replacement therapy: a meta-analysis of randomized controlled trials. Am J Kidney Dis 59:810–818PubMedCrossRef Wu MY, Hsu YH, Bai CH, Lin YF, Wu CH, Tam KW (2012) Regional citrate versus heparin anticoagulation for continuous renal replacement therapy: a meta-analysis of randomized controlled trials. Am J Kidney Dis 59:810–818PubMedCrossRef
2.
go back to reference Oudemans-van Straaten HM, Wester JP, de Pont AC, Schetz MR (2006) Anticoagulation strategies in continuous renal replacement therapy: can the choice be evidence based? Intensive Care Med 32:188–202PubMedCrossRef Oudemans-van Straaten HM, Wester JP, de Pont AC, Schetz MR (2006) Anticoagulation strategies in continuous renal replacement therapy: can the choice be evidence based? Intensive Care Med 32:188–202PubMedCrossRef
3.
go back to reference Monchi M, Berghmans D, Ledoux D, Canivet JL, Dubois B, Damas P (2004) Citrate vs. heparin for anticoagulation in continuous venovenous hemofiltration: a prospective randomized study. Intensive Care Med 30:260–265PubMedCrossRef Monchi M, Berghmans D, Ledoux D, Canivet JL, Dubois B, Damas P (2004) Citrate vs. heparin for anticoagulation in continuous venovenous hemofiltration: a prospective randomized study. Intensive Care Med 30:260–265PubMedCrossRef
4.
go back to reference Zappitelli M, Juarez M, Castillo L, Coss-Bu J, Goldstein SL (2009) Continuous renal replacement therapy amino acid, trace metal and folate clearance in critically ill children. Intensive Care Med 35:698–706PubMedCrossRef Zappitelli M, Juarez M, Castillo L, Coss-Bu J, Goldstein SL (2009) Continuous renal replacement therapy amino acid, trace metal and folate clearance in critically ill children. Intensive Care Med 35:698–706PubMedCrossRef
5.
go back to reference Symons JM, Chua AN, Somers MJ, Baum MA, Bunchman TE, Benfield MR, Brophy PD, Blowey D, Fortenberry JD, Chand D, Flores FX, Hackbarth R, Alexander SR, Mahan J, McBryde KD, Goldstein SL (2007) Demographic characteristics of pediatric continuous renal replacement therapy: a report of the prospective pediatric continuous renal replacement therapy registry. Clin J Am Soc Nephrol 2:732–738PubMedCrossRef Symons JM, Chua AN, Somers MJ, Baum MA, Bunchman TE, Benfield MR, Brophy PD, Blowey D, Fortenberry JD, Chand D, Flores FX, Hackbarth R, Alexander SR, Mahan J, McBryde KD, Goldstein SL (2007) Demographic characteristics of pediatric continuous renal replacement therapy: a report of the prospective pediatric continuous renal replacement therapy registry. Clin J Am Soc Nephrol 2:732–738PubMedCrossRef
6.
go back to reference Elhanan N, Skippen P, Nuthall G, Krahn G, Seear M (2004) Citrate anticoagulation in pediatric continuous venovenous hemofiltration. Pediatr Nephrol 19:208–212PubMedCrossRef Elhanan N, Skippen P, Nuthall G, Krahn G, Seear M (2004) Citrate anticoagulation in pediatric continuous venovenous hemofiltration. Pediatr Nephrol 19:208–212PubMedCrossRef
7.
go back to reference Chadha V, Garg U, Warady BA, Alon US (2002) Citrate clearance in children receiving continuous venovenous renal replacement therapy. Pediatr Nephrol 17:819–824PubMedCrossRef Chadha V, Garg U, Warady BA, Alon US (2002) Citrate clearance in children receiving continuous venovenous renal replacement therapy. Pediatr Nephrol 17:819–824PubMedCrossRef
8.
go back to reference Bunchman TE, Maxvold NJ, Brophy PD (2003) Pediatric convective hemofiltration: normocarb replacement fluid and citrate anticoagulation. Am J Kidney Dis 42:1248–1252PubMedCrossRef Bunchman TE, Maxvold NJ, Brophy PD (2003) Pediatric convective hemofiltration: normocarb replacement fluid and citrate anticoagulation. Am J Kidney Dis 42:1248–1252PubMedCrossRef
9.
go back to reference Askenazi DJ, Goldstein SL, Koralkar R, Fortenberry J, Baum M, Hackbarth R, Blowey D, Bunchman TE, Brophy PD, Symons J, Chua A, Flores F, Somers MJ (2013) Continuous renal replacement therapy for children </=10 kg: a report from the prospective pediatric continuous renal replacement therapy registry. J Pediatr 162(587–592):e583 Askenazi DJ, Goldstein SL, Koralkar R, Fortenberry J, Baum M, Hackbarth R, Blowey D, Bunchman TE, Brophy PD, Symons J, Chua A, Flores F, Somers MJ (2013) Continuous renal replacement therapy for children </=10 kg: a report from the prospective pediatric continuous renal replacement therapy registry. J Pediatr 162(587–592):e583
10.
go back to reference Strazdins V, Watson AR, Harvey B (2004) Renal replacement therapy for acute renal failure in children: European guidelines. Pediatr Nephrol 19:199–207PubMedCentralPubMedCrossRef Strazdins V, Watson AR, Harvey B (2004) Renal replacement therapy for acute renal failure in children: European guidelines. Pediatr Nephrol 19:199–207PubMedCentralPubMedCrossRef
11.
go back to reference Ronco C, Ricci Z (2008) Renal replacement therapies: physiological review. Intensive Care Med 34:2139–2146PubMedCrossRef Ronco C, Ricci Z (2008) Renal replacement therapies: physiological review. Intensive Care Med 34:2139–2146PubMedCrossRef
12.
go back to reference Akcan-Arikan A, Zappitelli M, Loftis LL, Washburn KK, Jefferson LS, Goldstein SL (2007) Modified RIFLE criteria in critically ill children with acute kidney injury. Kidney Int 71:1028–1035PubMedCrossRef Akcan-Arikan A, Zappitelli M, Loftis LL, Washburn KK, Jefferson LS, Goldstein SL (2007) Modified RIFLE criteria in critically ill children with acute kidney injury. Kidney Int 71:1028–1035PubMedCrossRef
14.
go back to reference Maclaren G, Butt W (2009) Controversies in paediatric continuous renal replacement therapy. Intensive Care Med 35:596–602PubMedCrossRef Maclaren G, Butt W (2009) Controversies in paediatric continuous renal replacement therapy. Intensive Care Med 35:596–602PubMedCrossRef
15.
go back to reference Morabito S, Pistolesi V, Tritapepe L, Zeppilli L, Polistena F, Strampelli E, Pierucci A (2012) Regional citrate anticoagulation in cardiac surgery patients at high risk of bleeding: a continuous veno-venous hemofiltration protocol with a low concentration citrate solution. Crit Care 16:R111PubMedCentralPubMedCrossRef Morabito S, Pistolesi V, Tritapepe L, Zeppilli L, Polistena F, Strampelli E, Pierucci A (2012) Regional citrate anticoagulation in cardiac surgery patients at high risk of bleeding: a continuous veno-venous hemofiltration protocol with a low concentration citrate solution. Crit Care 16:R111PubMedCentralPubMedCrossRef
16.
go back to reference Maxvold NJ, Smoyer WE, Custer JR, Bunchman TE (2000) Amino acid loss and nitrogen balance in critically ill children with acute renal failure: a prospective comparison between classic hemofiltration and hemofiltration with dialysis. Crit Care Med 28:1161–1165PubMedCrossRef Maxvold NJ, Smoyer WE, Custer JR, Bunchman TE (2000) Amino acid loss and nitrogen balance in critically ill children with acute renal failure: a prospective comparison between classic hemofiltration and hemofiltration with dialysis. Crit Care Med 28:1161–1165PubMedCrossRef
17.
go back to reference Santiago MJ, Lopez-Herce J, Urbano J, Solana MJ, del Castillo J, Ballestero Y, Botran M, Bellon JM (2010) Clinical course and mortality risk factors in critically ill children requiring continuous renal replacement therapy. Intensive Care Med 36:843–849PubMedCrossRef Santiago MJ, Lopez-Herce J, Urbano J, Solana MJ, del Castillo J, Ballestero Y, Botran M, Bellon JM (2010) Clinical course and mortality risk factors in critically ill children requiring continuous renal replacement therapy. Intensive Care Med 36:843–849PubMedCrossRef
18.
go back to reference Balogun RA, Turgut F, Caldwell S, Abdel-Rahman EM (2012) Regional citrate anticoagulation in critically ill patients with liver and kidney failure. J Nephrol 25:113–119PubMedCrossRef Balogun RA, Turgut F, Caldwell S, Abdel-Rahman EM (2012) Regional citrate anticoagulation in critically ill patients with liver and kidney failure. J Nephrol 25:113–119PubMedCrossRef
19.
go back to reference Schultheiss C, Saugel B, Phillip V, Thies P, Noe S, Mayr U, Haller B, Einwachter H, Schmid RM, Huber W (2012) Continuous venovenous hemodialysis with regional citrate anticoagulation in patients with liver failure: a prospective observational study. Crit Care 16:R162PubMedCentralPubMedCrossRef Schultheiss C, Saugel B, Phillip V, Thies P, Noe S, Mayr U, Haller B, Einwachter H, Schmid RM, Huber W (2012) Continuous venovenous hemodialysis with regional citrate anticoagulation in patients with liver failure: a prospective observational study. Crit Care 16:R162PubMedCentralPubMedCrossRef
20.
go back to reference Brophy PD, Somers MJ, Baum MA, Symons JM, McAfee N, Fortenberry JD, Rogers K, Barnett J, Blowey D, Baker C, Bunchman TE, Goldstein SL (2005) Multi-centre evaluation of anticoagulation in patients receiving continuous renal replacement therapy (CRRT). Nephrol Dial Transplant 20:1416–1421PubMedCrossRef Brophy PD, Somers MJ, Baum MA, Symons JM, McAfee N, Fortenberry JD, Rogers K, Barnett J, Blowey D, Baker C, Bunchman TE, Goldstein SL (2005) Multi-centre evaluation of anticoagulation in patients receiving continuous renal replacement therapy (CRRT). Nephrol Dial Transplant 20:1416–1421PubMedCrossRef
21.
go back to reference Bugg NC, Jones JA (1998) Hypophosphataemia. Pathophysiology, effects and management on the intensive care unit. Anaesthesia 53:895–902PubMedCrossRef Bugg NC, Jones JA (1998) Hypophosphataemia. Pathophysiology, effects and management on the intensive care unit. Anaesthesia 53:895–902PubMedCrossRef
22.
go back to reference Santiago MJ, Lopez-Herce J, Urbano J, Bellon JM, del Castillo J, Carrillo A (2009) Hypophosphatemia and phosphate supplementation during continuous renal replacement therapy in children. Kidney Int 75:312–316PubMedCrossRef Santiago MJ, Lopez-Herce J, Urbano J, Bellon JM, del Castillo J, Carrillo A (2009) Hypophosphatemia and phosphate supplementation during continuous renal replacement therapy in children. Kidney Int 75:312–316PubMedCrossRef
23.
go back to reference Hanley JA, Lippman-Hand A (1983) If nothing goes wrong, is everything all right? interpreting zero numerators. JAMA 249:1743–1745PubMedCrossRef Hanley JA, Lippman-Hand A (1983) If nothing goes wrong, is everything all right? interpreting zero numerators. JAMA 249:1743–1745PubMedCrossRef
24.
go back to reference Sutherland SM, Alexander SR (2007) Continuous renal replacement therapy in children. Pediatr Nephrol 27:2007–2016CrossRef Sutherland SM, Alexander SR (2007) Continuous renal replacement therapy in children. Pediatr Nephrol 27:2007–2016CrossRef
25.
go back to reference Parakininkas D, Greenbaum LA (2004) Comparison of solute clearance in three modes of continuous renal replacement therapy. Pediatr Crit Care Med 5:269–274PubMedCrossRef Parakininkas D, Greenbaum LA (2004) Comparison of solute clearance in three modes of continuous renal replacement therapy. Pediatr Crit Care Med 5:269–274PubMedCrossRef
26.
go back to reference Dorval M, Madore F, Courteau S, Leblanc M (2003) A novel citrate anticoagulation regimen for continuous venovenous hemodiafiltration. Intensive Care Med 29:1186–1189PubMedCrossRef Dorval M, Madore F, Courteau S, Leblanc M (2003) A novel citrate anticoagulation regimen for continuous venovenous hemodiafiltration. Intensive Care Med 29:1186–1189PubMedCrossRef
27.
go back to reference Gabutti L, Marone C, Colucci G, Duchini F, Schonholzer C (2002) Citrate anticoagulation in continuous venovenous hemodiafiltration: a metabolic challenge. Intensive Care Med 28:1419–1425PubMedCrossRef Gabutti L, Marone C, Colucci G, Duchini F, Schonholzer C (2002) Citrate anticoagulation in continuous venovenous hemodiafiltration: a metabolic challenge. Intensive Care Med 28:1419–1425PubMedCrossRef
28.
go back to reference Slater A, Shann F, Pearson G (2003) PIM2: a revised version of the paediatric index of mortality. Intensive Care Med 29:278–285PubMed Slater A, Shann F, Pearson G (2003) PIM2: a revised version of the paediatric index of mortality. Intensive Care Med 29:278–285PubMed
Metadata
Title
Regional citrate anticoagulation for pediatric CRRT using integrated citrate software and physiological sodium concentration solutions
Authors
Jean-Michel Liet
Emma Allain-Launay
Bénédicte Gaillard-LeRoux
François Barrière
Alexis Chenouard
Jean-Marc Dejode
Nicolas Joram
Publication date
01-09-2014
Publisher
Springer Berlin Heidelberg
Published in
Pediatric Nephrology / Issue 9/2014
Print ISSN: 0931-041X
Electronic ISSN: 1432-198X
DOI
https://doi.org/10.1007/s00467-014-2770-2

Other articles of this Issue 9/2014

Pediatric Nephrology 9/2014 Go to the issue